Search earnings tickers

REGN

2024Q2BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-08-01 · Fiscal end 2024-06-30 · Features as of 2024-07-31

← Earnings history

Street

Consensus EPS10.62

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.1%

IV front—

P/C full—

P/C front—

Features as of2024-07-31

Run-up

Close—

Ret 5d+1.7%

Ret 10d-0.6%

Ret 20d+3.3%

Ret 30d+3.2%

Print

Actual EPS

11.56Beat

Estimated EPS10.62

Actual revenue

3.5B

Surprise %+8.9%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction+3.0%

Implied vs actual

Implied 2.1%Actual 1.7%

Gap reaction-1.7%

Day result+1.3%

Next-day upYes

Realized / IV0.79×

Post tape

Post 5d+1.8%

Post 10d+7.5%

Post volume897.7K

Vol ×10d2.24×

Vol ×20d2.30×

Post range5.6%